ONCY•benzinga•
Oncolytics Biotech FY 2024 GAAP EPS C$(0.41) Beats C$(0.42) Estimate, Cash Position Of $15.9M Provides Runway Into Third Quarter 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 7, 2025 by benzinga